Medpage Today—March 25, 2016
Medpage Today writer Nancy Walsh covers a story about a new treatment option called arhalofenate for patients living with gout. According to the article, arhalofenate prevents the release of inflammatory cytokines involved with gout attacks.
Theodore R. Fields, MD, FACP, a rheumatologist at Hospital for Special Surgery, comments on the potential benefits of this course of treatment. "Patients who can't tolerate or are contraindicated for colchicine or low-dose NSAIDS -- a significant number of patients -- might especially benefit." Dr. Fields also notes that, "It will be of interest to see if the arhalofenate can be titrated higher than the 800 mg dose to see if greater urate lowering can be obtained."
To read the full article, visit MedpageToday.com.